Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Quest Diagnostics (NY:DGX)

176.51 -1.75 (-0.98%)
Official Closing Price Updated: 4:10 PM EST, Nov 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Quest Diagnostics

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Economic Crossroads: How Key Indicators Are Steering the Stock Market Through Moderation and Policy Shifts
The financial markets are currently navigating a complex and often contradictory economic landscape, heavily influenced by a suite of critical indicators such as jobs data and the Purchasing Managers'... 
Via MarketMinute
Topics Artificial Intelligence Economy Immigration
3 Low-Volatility Stocks We Think Twice About
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
3 Healthcare Stocks We Steer Clear Of
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This... 
Via StockStory
Topics Stocks
Why Guardant Health Stock Surged Today
The healthcare company's innovative cancer tests are helping to save lives. 
Via The Motley Fool
Price Over Earnings Overview: Quest Diagnostics
 
Via Benzinga
1 Profitable Stock to Target This Week and 2 Facing Challenges
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
Quest Diagnostics Inc (NYSE:DGX): A Dividend Stock Analysis for Income Investors
Quest Diagnostics (DGX) offers a strong dividend yield, steady growth, and sound financials for reliable income. Its manageable payout ratio ensures lasting payments. 
Via Chartmill
Quest Diagnostics Analysts Increase Their Forecasts After Q3 Earnings
 
Via Benzinga
Top S&P500 movers in Tuesday's session
Let's delve into the developments on the US markets one hour before the close of the markets on Tuesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Tuesday. Stay informed about the market activity below. 
Via Chartmill
Quest Diagnostics Reports Q3 Earnings, Shares Slide
Shares of Quest Diagnostics (NASDAQ: DGX) are falling Tuesday after the medical laboratories company shared mixed earnings results. 
Via Benzinga
Stay informed with the top movers within the S&P500 index on Tuesday.
Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
Gold Sinks 5% On Worst Day In 5 Years, Dow Jones Hits Record Highs: What's Moving Markets Tuesday?
Gold prices suffered a sharp correction on Tuesday as investors locked in profits following this year's explosive rally, while optimism across earnings kept industrial stocks powering higher and pushed... 
Via Benzinga
Topics Stocks
Which S&P500 stocks are gapping on Tuesday?
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Tuesday to find the gap up and gap down stocks in today's session. 
Via Chartmill
Tuesday's pre-market session: top gainers and losers in the S&P500 index
Stay updated with the S&P500 stocks that are on the move in today's pre-market session. 
Via Chartmill
Quest Diagnostics Inc (NYSE:DGX) Q3 2025 Earnings Top Estimates and Boost Full-Year Outlook
Quest Diagnostics (DGX) beat Q3 2025 earnings and revenue estimates, raising its full-year guidance and boosting its stock price. 
Via Chartmill
Quest (NYSE:DGX) Posts Better-Than-Expected Sales In Q3
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported revenue ahead of Wall Street’s expectations in Q3 CY2025, with sales up 13.2% year on year to $2.82 billion. The company’s full-year... 
Via StockStory
A Glimpse of Quest Diagnostics's Earnings Potential
 
Via Benzinga
Earnings Scheduled For October 21, 2025
 
Via Benzinga
Quest (DGX) Reports Earnings Tomorrow: What To Expect
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) will be reporting earnings this Tuesday before market hours. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
3 S&P 500 Stocks We Find Risky
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks
1 Cash-Producing Stock with Competitive Advantages and 2 We Brush Off
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
3 Low-Volatility Stocks with Open Questions
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
7 Analysts Have This To Say About Quest Diagnostics
 
Via Benzinga
Discover which S&P500 stocks are making waves on Tuesday.
Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
Wednesday's session: top gainers and losers in the S&P500 index
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday. 
Via Chartmill
bioAffinity Technologies Soars on Breakthrough Lung Cancer Diagnostic Data
bioAffinity Technologies, Inc. (NASDAQ: BIAF) has emerged as a standout performer in the financial markets today, September 26, 2025, with its stock experiencing a dramatic surge. The significant... 
Via MarketMinute
Topics Death
Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant’s Shield™ Blood-based Screening Test in the United States
From Guardant Health, Inc.
Via Business Wire
WHOOP to Bring Clinical Lab Testing from Quest Diagnostics to the WHOOP App
From WHOOP
Via Business Wire
Quest Diagnostics: A Solid Investment or a Risky Bet?
Join us as we analyze Quest Diagnostics and uncover whether this lab giant is a smart investment choice for the future. With insights from industry experts, you won't want to miss this evaluation! 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.